Accessibility Menu
 
Arrow-Thin-Down
S&P 500
7,412.84
+0.2%
+13.91
Arrow-Thin-Down
DJI
49,704.47
+0.2%
+95.31
Arrow-Thin-Down
NASDAQ
26,274.13
+0.1%
+27.05
Arrow-Thin-Down
Bitcoin
$81,735.00
-0.2%
-$154.58
Arrow-Thin-Down
AAPL
$292.54
-0.2%
-$0.51
Arrow-Thin-Down
AMZN
$268.77
-1.4%
-$3.91
Arrow-Thin-Down
GOOG
$386.63
-2.6%
-$10.42
Arrow-Thin-Down
META
$598.72
-1.8%
-$10.91
Arrow-Thin-Down
MSFT
$412.66
-0.6%
-$2.46
Arrow-Thin-Down
NVDA
$219.28
+1.9%
+$4.08
Arrow-Thin-Down
TSLA
$444.94
+3.9%
+$16.59
Most Active StocksDaily Stock GainersDaily Stock Losers
CervoMed logo

CervoMed

(NASDAQ) CRVO

Current Price$3.79
Market Cap$36.57M
Since IPO (2023)-48%
5 Year-92%
1 Year-56%
1 Month-2%

CervoMed Financials at a Glance

Market Cap

$36.57M

Revenue (TTM)

$322.57K

Net Income (TTM)

$26.97M

EPS (TTM)

$-2.97

P/E Ratio

-1.33

Dividend

$0.00

Beta (Volatility)

0.96 (Low)

Price

$3.79

Volume

540

Open

$3.90

Previous Close

$3.79

Daily Range

$3.76 - $3.94

52-Week Range

$3.51 - $13.13

CRVO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About CervoMed

Industry

Biotechnology

Sector

Health Care

Employees

15

CEO

John J. Alam, MD

Website

www.cervomed.com

Headquarters

Boston, MA 02116, US

CRVO Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-88%

Net Income Margin

-84%

Return on Equity

-94%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-75.19%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$36.57M

Shares Outstanding

9.26M

Volume

540

Avg. Volume

68.09K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$28.29M

EBITDA

$28.29M

Operating Cash Flow

$23.45M

Capital Expenditure

$0.00

Free Cash Flow

$23.45M

Cash & ST Invst.

$20.86M

Total Debt

$0.00

CervoMed Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$36.57M

N/A

Market Cap/Employee

$2.44M

N/A

Employees

15

N/A

Net Income

$8.09M

-20.6%

EBITDA

$8.33M

-15.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$20.86M

-46.4%

Accounts Receivable

$426.99K

-81.1%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.15%

N/A

Return on Invested Capital

-1.51%

N/A

Free Cash Flow

$6.58M

+18.3%

Operating Cash Flow

$6.58M

+18.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NTRBNutriband Inc.
$3.65-2.67%
LITSLite Strategy, Inc.
$1.24+1.64%
NRXPNRx Pharmaceuticals, Inc.
$2.82-8.44%
FBIOFortress Biotech, Inc.
$2.24-6.28%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$16.84+0.08%
NOKNokia
$13.92+0.09%
TQQQProShares Trust - ProShares UltraPro Qqq
$76.96+0.01%
CRCLCircle Internet Group
$131.76+0.16%

Questions About CRVO

What is the current price of CervoMed?

CervoMed is trading at $3.79 per share.

What is the 52-week range for CervoMed?

Over the past 52 weeks, CervoMed has traded between $3.51 and $13.13.

How much debt does CervoMed have?

As of the most recent reporting period, CervoMed reported total debt of N/A.

How much cash does CervoMed have on hand?

CervoMed reported $8.24M in cash and cash equivalents in its most recent financial results.

What is CervoMed’s dividend yield?

CervoMed does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services